NASDAQ:SRDX
SurModics Stock News
$26.17
+0 (+0%)
At Close: Apr 26, 2024
Surmodics to Report Second Quarter of Fiscal 2024 Financial Results on May 1
07:00am, Friday, 19'th Apr 2024
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)-- #EarningsCall--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announ
New Strong Buy Stocks for April 9th
07:16am, Tuesday, 09'th Apr 2024
SRDX, X, TELNY, INSP and MTAL have been added to the Zacks Rank #1 (Strong Buy) List on April 9, 2023.
Here's Why You Should Hold Surmodics (SRDX) Stock for Now
12:30pm, Wednesday, 20'th Mar 2024
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Surmodics (SRDX) Q1 Earnings Top Estimates, Revises FY24 View
11:16am, Friday, 02'nd Feb 2024
Surmodics (SRDX) reports a solid fiscal first quarter top line on the back of robust segmental revenues.
Surmodics, Inc (SRDX) Q1 2024 Earnings Call Transcript
02:41pm, Thursday, 01'st Feb 2024
Surmodics, Inc (SRDX) Q1 2024 Earnings Call Transcript
SurModics (SRDX) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:37am, Thursday, 01'st Feb 2024
The headline numbers for SurModics (SRDX) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street est
SurModics (SRDX) Reports Break-Even Earnings for Q1
09:10am, Thursday, 01'st Feb 2024
SurModics (SRDX) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.35. This compares to loss of $0.50 per share a year ago.
Surmodics' (SRDX) New Device to Boost Its Thrombectomy Platform
11:16am, Tuesday, 23'rd Jan 2024
Surmodics (SRDX) new addition to its Pounce Thrombectomy Platform is recommended for use in vessels with a diameter between 2 mm and 4 mm for clot removal.
SurModics (SRDX) Soars 6.2%: Is Further Upside Left in the Stock?
08:16am, Thursday, 14'th Dec 2023
SurModics (SRDX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
12:47pm, Tuesday, 12'th Dec 2023
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
2 Highly Ranked Medical Stocks to Consider After Healthy Quarterly Results
09:48pm, Thursday, 09'th Nov 2023
After impressive quarterly results on Wednesday, here are two highly-ranked Zacks Medical sector stocks that investors may want to consider.
Surmodics (SRDX) Q4 Earnings Top Estimates, Revenues Up Y/Y
02:17pm, Thursday, 09'th Nov 2023
Surmodics (SRDX) reports a solid fiscal fourth quarter top line on the back of robust segmental revenues.
Snap These 4 Top-Ranked Liquid Stocks for Solid Returns
08:16am, Tuesday, 31'st Oct 2023
Here are four top-performing liquid stocks, Deckers Outdoor (DECK), Surmodics (SRDX), NVIDIA (NVDA) and Sprinklr (CXM), which investors can add to their portfolio for solid returns.
3 Reasons to Add Surmodics (SRDX) Stock to Your Portfolio
12:47pm, Tuesday, 10'th Oct 2023
Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
Add These 4 Top-Ranked Liquid Stocks to Strengthen Portfolio
09:01am, Monday, 25'th Sep 2023
Here are four top-ranked liquid stocks, Surmodics (SRDX), Fluor Corporation (FLR), NVIDIA (NVDA) and Sprinklr (CXM), which investors can add to their portfolio for solid gains.